Key Market Indicators
Sales of antidepressant medications in Canada are expected to reach $968.66 million by 2026. This is a slight decrease of 1.3% from 2021's figure of $1.08 billion, according to research. Between 2017 and 2021, the Canadian market rose by an average of 0.2% year on year. Germany, Spain and Italy ranked second, third and fourth in this market, respectively.
